[Polaris Group] March 2026 Revenue NT$2M (YoY -59.7%)
NQ Score
17/100
N1 Content Completeness
1
AI Summary (NQ-processed)
Biopharmaceutical company Polaris Group (code: 6550) reported monthly revenue of NT$1.57 million for March 2026, a 59.7% decrease year-on-year, likely reflecting the progress of clinical trials and the pre-product launch stage.